PetMed Express Reports Q4 Loss of $0.19/Share, Significantly Better Than Expected
Reported by Reuters
Sentiment
Positive
Importance
8
Price
$2.2
Mkt Cap
$45.583M
52W Low
$1.57
52W High
$4.32
Market data snapshot near publication time
Summary
PetMed Express announced Q4 revenue of $42.8 million and an EPS loss of $0.19. This reported loss is significantly better than the $0.41 loss per share analysts had anticipated for the quarter. The company's last 10-Q had indicated a substantial net loss, making this a positive surprise.
At the time of this announcement, PETS was trading at $2.20 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $45.6M. The 52-week trading range was $1.57 to $4.32. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.